-+ 0.00%
-+ 0.00%
-+ 0.00%

BIPROGY (TSE:8056) Stock Looks Fairly Valued After Its 61% Five Year Run

Simply Wall St·11/01/2026 04:47:38
语音播报

BIPROGY has delivered a 61.4% gain over the past 5 years, yet the current share price of ¥4,939 still raises a basic question for investors who care about cash returns. Are the cash flows that BIPROGY can generate over time enough to justify where the stock trades today, when viewed through a Discounted Cash Flow (DCF) lens?

  • That 61.4% share price rise over 5 years puts real weight on whether BIPROGY's future cash generation can match what the market has already priced in.
  • The business model relies heavily on turning software and IT services revenue into dependable free cash flow, which can shape how sensitive the intrinsic value is to even modest shifts in margins or contract timing.
  • What if you looked at BIPROGY through its earnings instead? See why BIPROGY's 16.0x P/E tells a different valuation story.

The issue now is whether the cash flows BIPROGY is expected to produce, once discounted back through the Discounted Cash Flow (DCF) framework, stack up against today's ¥4,939 share price.

If you like testing whether today's BIPROGY share price lines up with its cash flows, you may want to run the same check across 15 high quality undervalued stocks.

Is BIPROGY Fairly Priced on Cash Flow?

The Discounted Cash Flow (DCF) approach here looks at the cash BIPROGY can return to shareholders over time and discounts it back to today. Latest twelve month free cash flow sits at about ¥35.6b, which gives the model a reasonably solid base rather than forcing it to lean on very distant cash flow years.

Analysts and internal estimates feed in a growing free cash flow profile through to 2031 and beyond, with projected amounts still in the tens of billions of ¥ each year. When those streams are discounted back, the result lines up broadly with the current ¥4,939 share price. This suggests the market is already incorporating these cash flow expectations into the price. For anyone weighing whether BIPROGY offers enough of a margin between price and estimated worth, the detailed output of this DCF shows how sensitive that balance is to small shifts in future cash flow. Find out what BIPROGY could be worth using our Discounted Cash Flow (DCF) estimate.

The BIPROGY Narrative: What Would Justify Today's Price?

Narratives for BIPROGY pick up where the DCF puzzle leaves off and spell out which paths for revenue, margins and earnings would need to play out for the stock to be worth meaningfully more or less than it is today, all housed on Simply Wall St's Community page. Instead of a single output from a ratio or model, you see the specific future that figure assumes. This lets you watch over time whether BIPROGY's actual progress tracks that story.

A clear, number-driven Narrative on BIPROGY gives you a reference point for where its growth, margins and execution might reasonably head next, instead of leaving those expectations vague in the background. Once those assumptions are written down, you can test them against each new result and see whether the business is actually tracing the path that would make today's price look attractive or demanding.

Share your own Narrative for BIPROGY and set out the assumptions behind your valuation.

The BIPROGY share price is only one piece of the decision

Before you lean too hard on the DCF output, check who is steering BIPROGY and how their pay packets line up with your interests. See who runs BIPROGY and how they are paid.